- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x KTD: 1-(1,2,3-benzothiadiazol-6-yl)-3-(2-oxo-2-phenylethyl)urea(Non-covalent)
- 34 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
UNX.2: 3 residues within 4Å:- Chain A: E.97, Y.100, K.119
Ligand excluded by PLIPUNX.3: 2 residues within 4Å:- Chain A: V.125, H.126
Ligand excluded by PLIPUNX.4: 1 residues within 4Å:- Chain A: E.269
Ligand excluded by PLIPUNX.5: 3 residues within 4Å:- Chain A: Y.196, G.197
- Chain B: R.53
Ligand excluded by PLIPUNX.6: 2 residues within 4Å:- Chain A: D.217, K.219
Ligand excluded by PLIPUNX.7: 3 residues within 4Å:- Chain A: E.138, W.139, M.140
Ligand excluded by PLIPUNX.8: 3 residues within 4Å:- Chain A: K.184, L.216, D.217
Ligand excluded by PLIPUNX.9: 3 residues within 4Å:- Chain A: S.180, S.255, M.256
Ligand excluded by PLIPUNX.10: 2 residues within 4Å:- Chain A: K.229, H.230
Ligand excluded by PLIPUNX.11: 2 residues within 4Å:- Chain A: F.300, S.301
Ligand excluded by PLIPUNX.12: 2 residues within 4Å:- Chain A: C.202, K.205
Ligand excluded by PLIPUNX.13: 3 residues within 4Å:- Chain A: P.282, Q.283, S.284
Ligand excluded by PLIPUNX.14: 4 residues within 4Å:- Chain A: T.173, G.227, I.228, K.229
Ligand excluded by PLIPUNX.15: 4 residues within 4Å:- Chain A: Y.267, R.275, V.276, V.277
Ligand excluded by PLIPUNX.16: 4 residues within 4Å:- Chain A: H.185, A.186, I.189, A.190
Ligand excluded by PLIPUNX.17: 2 residues within 4Å:- Chain A: V.215, K.290
Ligand excluded by PLIPUNX.18: 2 residues within 4Å:- Chain A: K.184, D.187
Ligand excluded by PLIPUNX.20: 3 residues within 4Å:- Chain B: E.97, Y.100, K.119
Ligand excluded by PLIPUNX.21: 2 residues within 4Å:- Chain B: V.125, H.126
Ligand excluded by PLIPUNX.22: 1 residues within 4Å:- Chain B: E.269
Ligand excluded by PLIPUNX.23: 3 residues within 4Å:- Chain A: R.53
- Chain B: Y.196, G.197
Ligand excluded by PLIPUNX.24: 2 residues within 4Å:- Chain B: D.217, K.219
Ligand excluded by PLIPUNX.25: 3 residues within 4Å:- Chain B: E.138, W.139, M.140
Ligand excluded by PLIPUNX.26: 3 residues within 4Å:- Chain B: K.184, L.216, D.217
Ligand excluded by PLIPUNX.27: 3 residues within 4Å:- Chain B: S.180, S.255, M.256
Ligand excluded by PLIPUNX.28: 2 residues within 4Å:- Chain B: K.229, H.230
Ligand excluded by PLIPUNX.29: 2 residues within 4Å:- Chain B: F.300, S.301
Ligand excluded by PLIPUNX.30: 2 residues within 4Å:- Chain B: C.202, K.205
Ligand excluded by PLIPUNX.31: 3 residues within 4Å:- Chain B: P.282, Q.283, S.284
Ligand excluded by PLIPUNX.32: 4 residues within 4Å:- Chain B: T.173, G.227, I.228, K.229
Ligand excluded by PLIPUNX.33: 4 residues within 4Å:- Chain B: Y.267, R.275, V.276, V.277
Ligand excluded by PLIPUNX.34: 4 residues within 4Å:- Chain B: H.185, A.186, I.189, A.190
Ligand excluded by PLIPUNX.35: 2 residues within 4Å:- Chain B: V.215, K.290
Ligand excluded by PLIPUNX.36: 2 residues within 4Å:- Chain B: K.184, D.187
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, F. et al., Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors. J. Med. Chem. (2013)
- Release Date
- 2012-12-05
- Peptides
- PRMT3 protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.30 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x KTD: 1-(1,2,3-benzothiadiazol-6-yl)-3-(2-oxo-2-phenylethyl)urea(Non-covalent)
- 34 x UNX: UNKNOWN ATOM OR ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, F. et al., Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors. J. Med. Chem. (2013)
- Release Date
- 2012-12-05
- Peptides
- PRMT3 protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A